Navigation Links
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
Date:7/12/2012

LIVERMORE, Calif. Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Lab officials are seeking industry partners to license and commercialize the SpinDx technology, which can determine a patient's white blood cell count, analyze important protein markers, and process up to 64 assays from a single sample, all in a matter of minutes.

"In a doctor's office, time is money," said Anup Singh, manager of Sandia's biotechnology and bioengineering department. "Patients have become accustomed to an initial visit, some tests, samples that are sent off to a far-away lab, a wait of a week or more for results, more tests and charges every step of the way. With SpinDx, you can see results before you even leave the office."

(Visit www.youtube.com/SandiaLabs to view HD video footage of the "SpinDx" medical diagnostic tool)

The technology advances in SpinDx have profound implications for patient care. Heart attacks, strokes, infections, certain cancers and other afflictions could be detected days or weeks sooner than they are today, with no new burdens placed on patients or their doctors, Singh said.

The SpinDx platform has several advantages:

  • Small sample size: Patients merely have to provide a pin-prick sample of blood.
  • Ease of use: The device uses a spinning disk, much like a CD player, to manipulate a sample. The disks contain commercially available reagents and antibodies specific to each protein marker.
  • Custom applications: Singh envisions a "plug and play" approach whereby the physician chooses among a "cardiac disk," "immune disk" and similar options.
  • Inexpensive technology: The disks the crux of the technology cost pennies to manufacture.
  • Quick response time: Results can b
    '/>"/>

Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Miniature Sandia sensors may advance climate studies
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. F1000 Research partners with figshare to provide smart ways of accessing data
7. Royal Astronomical Society and Oxford University Press partnership announced
8. Grants add to Northwestern-Qatar partnership
9. New museum-university partnership ushers in new era of environmental science education
10. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
11. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:1/22/2015)... Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), ... general the State of Washington,s Department ... new enrollment and central issuance system for driver,s licenses and ... The project planning and development will start in January 2015, ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... Angelman syndrome, a neurological disorder that causes mental retardation ... has been developed by biologists at The University of ... a particular fruit fly gene, dube3a, is altered, the ... by humans whose UBE3A gene doesn,t function normally. ...
... MSG, as a flavor enhancer in their food are more likely ... even though they have the same amount of physical activity and ... Chapel Hill School of Public Health study published this month in ... China studied more than 750 Chinese men and women, aged between ...
... a deep-sea bloodhound, Sentry the newest in an ... their own in demanding and rugged environments has ... of a pioneering seafloor laboratory being planned off Washington ... a crucial step in developing an extensive sensor network ...
Cached Biology News:Model for angelman syndrome developed by University of Texas at Austin biologists 2UNC researchers find MSG use linked to obesity 2New robot scouts best locations for components of undersea lab 2New robot scouts best locations for components of undersea lab 3
(Date:2/26/2015)... Already well respected for accuracy, HEIDENHAIN ... its Length Gauge offerings with new variants of its ... Specifically, HEIDENHAIN’s pencil probe-style SPECTO length gauge series now ... new 1Vpp, 12mm stroke length variants of the SPECTO ... a variant with a weak spring, 0.4N of gauging ...
(Date:2/26/2015)... 26, 2015 RURO, Inc., a leading ... version 6.2 – the latest update to the bestselling ... that of a quick and easy method to gain ... latest version, RURO engineering has enhanced the system’s support ... large amounts of sample records. , "FreezerPro has ...
(Date:2/26/2015)... , Feb. 26, 2015  Dyadic International, ... whose patented and proprietary technologies are used to ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... its financial results for year ending December 31, ... 2015 and will host a conference call that ...
(Date:2/26/2015)... 2015 Ceres, Inc . today announced ... PartnerNetwork. In attaining Gold Level membership, Ceres has been ... knowledge in delivering Ceres, Persephone genome visualization software and ... Originally developed for in-house use by Ceres, the ... out of massive amounts of genetic data, from a ...
Breaking Biology Technology:Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2RURO Releases FreezerPro® version 6.2 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4
... 16 IR BioSciences,Holdings, Inc. (OTC Bulletin Board: ... and CEO Michael K. Wilhelm. The purpose of ... shareholders on its subsidiary,ImmuneRegen BioSciences, past year of ... ImmuneRegen today has also filed a Form,8-K containing ...
... in the Fourth ... Quarter, ... from a 12-week, Phase 3 clinical,trial of FENTORA(R) (fentanyl buccal tablet) [C-II] ... pain,conditions. The study achieved statistical significance on the primary,endpoint. Results across the ...
... CITY, Aug. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TSX: ... on,endocrine therapy and oncology, today announced the filling ... the appointment of Paul Blake,M.D., as Senior Vice ... of Dr. Blake is timely and critical as ...
Cached Biology Technology:ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 2ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 3ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 2Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 3Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 5AEterna Zentaris completes management team with the appointment of Chief Medical Officer 2AEterna Zentaris completes management team with the appointment of Chief Medical Officer 3